Marlborough, MA, April 24, 2017 – Proveris Scientific Corporation, a leading organization engaged in advancing the science of nasal and inhaled drug delivery, has joined The International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS) as an associate member. IPAC-RS is a highly respected technical resource and industry advocate for enhancing product quality for the […]
Marlborough, MA, April 19, 2016 – Proveris Scientific Corporation announced today that the Company’s SprayVIEW® measurement system was used by Summit Biosciences during development of the first generic unit dose nasal spray product approved by the FDA. Approval of the abbreviated new drug application (ANDA) for Sumatriptan nasal spray USP, 5 mg and 20 mg […]
GSK opens new £56 million inhaler manufacturing facility
Apotex launches generic version of Nasonex in the US
DPT will be presenting a poster, co-authored with Proveris Scientific, at the RDD 2016 in Scottsdale, Arizona. This event will take place from April 17th through the 21st, 2016. Proveris will also host an Exhibition Table (#63) and encourage attendees to stop by and learn about our products and services, including our new Viota® Software Unit Dose Module.
Proveris Scientific is a proud Gold Sponsor of, and is presenting at Aptar Pharma China’s 6th Innovative Drug Delivery Solutions (IDDS) Symposium! Dino Farina, CEO, is giving a presentation titled, “Succeeding with Nasal Spray and Metered Dose Inhaler Product Development Using a Structured Approach”. He is also serving as conference chairman during a discussion on dry powder inhalers (DPI). […]
Proveris Scientific is a proud Gold Sponsor of, and will be presenting at Aptar Pharma China’s 6th Innovative Drug Delivery Solutions (IDDS) Symposium! The 6th IDDS symposium will be held from 14-16th of March, 2016 at the Nanlin Hotel in Suzhou, China. Check back in the coming weeks for more information about the symposium and Proveris’s […]